Biotech Test
Terms
undefined, object
copy deck
-
Daclizumab
(Zenapax) -
-humanized monoclonal ab to IL-2R alpha
-prophylaxis of renal transplant rejection
-binds to IL-2 receptor on T-helper cells -
Basiliximab
(Simulect) -
-humanized monoclonal ab to IL-2R alpha
-renal, lier transplant rejection prophylaxis
-blocks binding of IL-2 to the IL-2R alpha subunit -
Abciximab
(ReoPro) - -humanized Fab fragment that binds to glycoprotein IIb/IIIa receptor of platelets blocking aggregation
-
Infliximab
(Remicade) -
-humanized monoclonal ab to TNF-alpha
I:Crohn's disease, RA
-binds and neuralizes TNF-alpha -
Adalimumab
(HUMIRA) -
-true human monoclonal to TNF-alpha
I:RA
-prefilled syringe w/plastic wings -
Rituximab
(Rituxan) -
-humanized monoclonal ab against CD-20
I:non-Hodgkin's lymphoma(relapsed or refractory),chronic lymhocytic leukemia, RA, macroglobulinemi, Walenstroms
-1st mab approved for cancer. CD20 is early signalling for cancer -
Alemtuzumab
(Campath) -
-humanized mab against CD-20
I:B-cell chronic lymphocytic leukemia
-watch CD4+ count -
Efalizumab
(Raptiva) -
-humanized mab against CD11a
I:plaque psoriasis (mod/severe)
-blocks binding to ICAM-1 required for cell commumication -
Trastuzumab
(Herceptin) -
-humanized mab against HER-2
I:breast cancer
-some pts have anaphylactic reactions -
Cetuximab
(Erbitux) -
-chimeric mab to EGFR
I:colorectral cancer,squamous cell cacinoma
-Martha's drug, requires +EGFR expression